Azomycin

Azomycin

SCHEMBL8400797

O=[N+]([O-])c1ncc[nH]1.[Na]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Azomycin SCHEMBL10049 0.98
Azomycin SCHEMBL3804535 0.98 MEN1 (0.46)
Azomycin SCHEMBL29116196 0.95
Azomycin SCHEMBL4231042 0.95
Azomycin SCHEMBL29413971 0.95 MEN1 (0.44)
Azomycin SCHEMBL4349167 0.95
Azomycin SCHEMBL4349164 0.95
Azomycin SCHEMBL4553768 0.95
Azomycin SCHEMBL31554956 0.95
Azomycin SCHEMBL28751634 0.95

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112778364-B Nitroimidazole derivative and preparation method and application thereof 华创合成制药股份有限公司 2023-12-08 CN disclosed
US-5958947-A SENSITIZERS FOR CANCER THERAPY EVANSTON HOSPITAL (US) 1999-09-28 US disclosed
US-5602142-A PROMOTER FOR IMPROVING RADIOSENSITIZATION AND CHEMOSENSITIZATION EVANSTON HOSPITAL CORPORATION (US) 1997-02-11 US disclosed